Suchergebnisse - "Ohara, Kosuke"

PubPharm (8)

1

Weak Inhibitory Effects of Anthocyanins on Human Aldehyde Oxidase Activity : An In Vitro Study

enthalten in: Journal of nutritional science and vitaminology | 2023

von Shibata, Y. | Matsumoto, K. | Hasegawa, T. | +2

2

Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone : Baeyer-Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acid in vitro

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2021

von Matsumoto, K. | Hasegawa, T. | Ohara, K. | +3

3

Total Anthocyanin Content, Total Phenolic Content, and Antioxidant Activity of Various Blueberry Cultivars Grown in Togane, Chiba Prefecture, Japan

enthalten in: Journal of nutritional science and vitaminology | 2021

von Shibata, Y. | Ohara, K. | Matsumoto, K. | +2

4

Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer–Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acidin vitro

enthalten in: Xenobiotica | 2021

von Matsumoto, K. | Hasegawa, T. | Ohara, K. | +3

5

A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2020

von Matsumoto, K. | Hasegawa, T. | Ohara, K. | +5

6

A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes

enthalten in: Xenobiotica | 2020

von Matsumoto, K. | Hasegawa, T. | Ohara, K. | +5

7

Roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone

enthalten in: Journal of pharmaceutical investigation | 2020

von Matsumoto, K. | Hasegawa, T. | Ohara, K. | +2

8

Roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone

enthalten in: Journal of pharmaceutical investigation | 2019

von Matsumoto, K. | Hasegawa, T. | Ohara, K. | +2

1
[1]